| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYSB2101229 | 静注乙型肝炎人免疫球蛋白（pH4) | human hepatitis B immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2021-10-19 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | view |